Literature DB >> 25151323

Basic science: Pathophysiology: the cardiorenal metabolic syndrome.

Adam Whaley-Connell, James R Sowers.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25151323      PMCID： PMC4170524          DOI： 10.1016/j.jash.2014.07.003

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN： 1878-7436


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic strategies for heart failure in cardiorenal syndromes.

Authors:  Andrew A House; Mikko Haapio; Johan Lassus; Rinaldo Bellomo; Claudio Ronco
Journal:  Am J Kidney Dis       Date:  2010-06-16       Impact factor: 8.860

2.  Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies.

Authors:  Daniel L McGee
Journal:  Ann Epidemiol       Date:  2005-02       Impact factor: 3.797

3.  Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.

Authors:  Gilles R Dagenais; Qilong Yi; Johannes F E Mann; Jackie Bosch; Janice Pogue; Salim Yusuf
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  Body mass index and risk for end-stage renal disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Carlos Iribarren; Jeanne Darbinian; Alan S Go
Journal:  Ann Intern Med       Date:  2006-01-03       Impact factor: 25.391

6.  The Role of Overweight and Obesity in the Cardiorenal Syndrome.

Authors:  James R Sowers; Adam Whaley-Connell; Melvin R Hayden
Journal:  Cardiorenal Med       Date:  2011-01-17       Impact factor: 2.041

7.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

Review 8.  Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

Authors:  Richard J Johnson; Mark S Segal; Yuri Sautin; Takahiko Nakagawa; Daniel I Feig; Duk-Hee Kang; Michael S Gersch; Steven Benner; Laura G Sánchez-Lozada
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

9.  Obesity and the metabolic syndrome in children and adolescents.

Authors:  Ram Weiss; James Dziura; Tania S Burgert; William V Tamborlane; Sara E Taksali; Catherine W Yeckel; Karin Allen; Melinda Lopes; Mary Savoye; John Morrison; Robert S Sherwin; Sonia Caprio
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  The metabolic syndrome and chronic kidney disease in U.S. adults.

Authors:  Jing Chen; Paul Muntner; L Lee Hamm; Daniel W Jones; Vecihi Batuman; Vivian Fonseca; Paul K Whelton; Jiang He
Journal:  Ann Intern Med       Date:  2004-02-03       Impact factor: 25.391
View more
  9 in total

Review 1.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

2.  Peripheral Edema, Central Venous Pressure, and Risk of AKI in Critical Illness.

Authors:  Kenneth P Chen; Susan Cavender; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal; John Danziger
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-19       Impact factor: 8.237

Review 3.  The role of copeptin in kidney disease.

Authors:  Pedro Iglesias; Ramona A Silvestre; María José Fernández-Reyes; Juan J Díez
Journal:  Endocrine       Date:  2022-10-15       Impact factor: 3.925

4.  Utility of obesity and metabolic dyslipidemia (a non-insulin based determinate of the metabolic syndrome and insulin resistance) in predicting arterial stiffness.

Authors:  Annayya R Aroor; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-18       Impact factor: 3.738

Review 5.  Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.

Authors:  Luis D'Marco; María Jesús Puchades; Lorena Gandía; Claudia Forquet; Elena Giménez-Civera; Nayara Panizo; Javier Reque; Isabel Juan-García; Valmore Bermúdez; José Luis Gorriz
Journal:  touchREV Endocrinol       Date:  2021-11-10

6.  Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.

Authors:  Annayya R Aroor; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

7.  CARDIO-RENAL METABOLIC SYNDROME AND PRO-INFLAMMATORY FACTORS: THE DIFFERENTIAL EFFECTS OF DIETARY CARBOHYDRATE AND FAT.

Authors:  M A Farhangi; M Mesgari-Abbasi; P Shahabi
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

Review 8.  Nitric oxide signalling in kidney regulation and cardiometabolic health.

Authors:  Mattias Carlström
Journal:  Nat Rev Nephrol       Date:  2021-06-01       Impact factor: 28.314

Review 9.  Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome.

Authors:  Jois Preeti; Mebazaa Alexandre; Iyngkaran Pupalan; Thomas C Merlin; Ronco Claudio
Journal:  Curr Cardiol Rev       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.